BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 28, 2002
View Archived Issues
AltaRex Plans U.S. Filing Despite Mixed Results Of OvaRex Trials
Despite inconsistent results in Phase IIb trials, Canadian company AltaRex Corp. intends this year to file a rolling biologics license application for its late-stage ovarian cancer drug, OvaRex.
Read More
Trimeris Raising $41M Privately As It Eyes NDA For HIV Drug
Read More
Hunt For Signs Of Life On Mars Gets Boost From Live Archaea Deep Under Idaho Hot Springs
Read More
Intradigm, DirectGene Team Up To Develop Cancer Therapeutics
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More